Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Recapitalization Transaction Expense (Tables)

v3.22.1
Recapitalization Transaction Expense (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Recapitalization Transaction Expense [Abstract]  
Summary of Displays Calculation of Recapitalization Transaction Expense
The following table displays the calculation of the Recapitalization transaction expense:

Amount Number of shares/warrants
$’000
(a) Alkuri Ordinary Shares 12,267,653 
(b) Opening price of Babylon Ordinary Shares on NYSE as of October 22, 2021 10.01
(c) Fair value of Company shares issued to Alkuri shareholders (a*b) 122,799 
(d) Outstanding Alkuri Warrants on October 22, 2021 14,558,333 
(e) Opening price of Babylon Warrants on NYSE as of October 22, 2021
 Public warrants 2.13 8,625,000 
 Private placement warrants 2.13 5,933,333 
(f) Fair value of outstanding Alkuri Warrants (d*e) 31,009 
Total fair value of Alkuri Ordinary Shares and Alkuri Warrants (c+f) 153,808 
Alkuri’s identifiable net assets 5,310 
IFRS 2 Expense on the closing date 148,498 
PIPE Transaction
(a) PIPE Ordinary Shares 22,400,000 
(b) Opening price of Babylon Ordinary Shares on NYSE as of October 22, 2021 10.01
(c) Fair value of Company shares issued to PIPE investors (a*b) 224,224 
PIPE’s identifiable net assets 224,000 
IFRS 2 Expense on the closing date 224 
Total IFRS 2 Expense 148,722 
Total cash proceeds received 229,311 
Expense of share issue (32,787)
Cash proceeds 196,524